US 9365848
Modulation of apolipoprotein C-III expression
granted A61KA61K38/00A61P
Quick answer
US patent 9365848 (Modulation of apolipoprotein C-III expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61P, A61P3/00, A61P3/04